Non-neurologic manifestations of tuberous sclerosis complex

Journal of Child Neurology

Volumn 19, Issue 9, 2004, Pages 690-698

  Franz, David Neal ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CORTICOSTEROID; PROGESTERONE; RAPAMYCIN;

ANGIOMYOLIPOMA; COMPUTER ASSISTED TOMOGRAPHY; GENETIC DISORDER; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; LIFESPAN; LUNG DISEASE; LYMPHANGIOLEIOMYOMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TUBEROUS SCLEROSIS;

EID: 8844236164     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738040190091001     Document Type: Review

References (39)

1. Casper KA, Donnelly LF, Chen B, Bissler JJ: Tuberous sclerosis complex: Renal imaging findings. Radiology 2002;225:451-456.
2. Neumann HP, Schwarzkopf G, Henske EP: Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex. Semin Pediatr Neurol 1998;5:269-275.
3. Piattelli A, Fioroni M, Rubini C, Fiera E: Angiomyolipoma of the patate, report of a case. Oral Oncol 2002;37:323-325.
4. Fujii Y, Ajima J, Oka K, et al: Benign renal tumors detected among healthy adults by abdominal ultrasonography. Eur Urol 1995;27: 124-127.
5. Henske EP, Neumann HP, Scheithauer BW, et al: Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 1995;13: 295-298.
6. Green AJ, Smith M, Yates JR: Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 1994;6:193-196.
7. Sepp T, Yates JR, Green AJ: Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 1996;33:962-964.
8. Koh KG, George J: Radiological parameters of bleeding renal angiomyolipoma. Scand J Urol Nephrol 1996;30:265-268.
9. van Baal JG, Smits NJ, Keeman JN, et al: The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol 1994;152:43-44.
10. Kennelly MJ, Grosman HB, Cho KJ: Outcome analysis of 42 cases of renal angiomyolipoma. J Urol 1994;152(6 Pt 1):1988-1991.
11. Hyman MH, Whittemore VH: National Institutes of Health consensus conference: Tuberous sclerosis complex. Arch Neurol 2000;57:662-665.
12. Roach ES, DiMario FJ, Kandt RS, Northrup H: Tuberous Sclerosis Consensus Conference: Recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 1999;14:401-407.
13. Harabayashi T, Shinohara N, Katano H, et al: Management of renal angiomyolipomas associated with tuberous sclerosis complex. J Urol 2004;171:102-105.
14. Nelson CP, Sanda MG: Contemporary diagnosis and management of renal angiomyolipoma, review. J Urol 2002;168(4 Pt 1): 1315-1325.
15. Bissler JJ, Racadio J, Donnelly LF, Johnson ND: Reduction of postembolization syndrome after ablation of renal angiomyolipoma. Am J Kidney Dis 2002;39:966-971.
16. El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ: Mutation in TSC2 and activation of mammalian target of rapamycin signaling pathway in renal angiomyolipoma. Lancet 2003;361:1348-1349.
17. Kim JK, Park SY, Shon JH, Cho KS: Angiomyolipoma with minimal fat: Differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004;230:677-684.
18. Tello R, Blickman JG, Buonomo C, Herrin J: Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol 1998;27:131-138.
19. Castro M, Shepherd CW, Gomez MR, et al: Pulmonary tuberous sclerosis. Chest 1995;107:189-195.
20. Wilson AM, Slack HL, Soosay SA, et al: Lymphangioleiomyomatosis. A series of three case reports illustrating the link with high oestrogen states. Scott Med J 2001;46:150-152.
21. Banner AS, Carrington CB, Emory WB, et al: Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N Engl J Med 1981;305:204-209.
22. Aubry MC, Myers JL, Ryu JH, et al: Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med 2000;162 (2 Pt 1):749-752.
23. Franz DN, Brody A, Meyer C, et al: Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 2001;164:661-668.
24. Costello LC, Hartman TE, Ryu JH: High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000;75:591-594.
25. Taylor JR, Ryu J, Colby TV, Raffin TA: Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990;323: 1254-1260.
26. Smolarek TA, Wessner LL, McCormack FX, et al: Evidence that lymphangiomyomatosis is caused by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 1998;62:810-815.
27. Carsillo T, Astrinidis A, Henske EP: Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 2000;97: 6085-6090.
28. Astrinidis A, Khare L, Carsillo T, et al: Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet 2000;37:55-57.
29. Karbowniczek M, Astrinidis A, Balsara BR, et al: Recurrent lymphangioleiomyomatosis after transplantation genetic analysis reveal a metastatic mechanism. Am J Respir Crit Care Med 20031;167:976-982.
30. Bader RS, Chitayat D, Kelly E, et al: Fetal rhabdomyoma: Prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex. J Pediatr 2003;143:620-624.
31. Jozwiak S: Cardiac and vascular involvement, in Curatolo P, ed: Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. London, MacKeith Press, 2003;196-214.
32. Shiono J, Horigome H, Yasui S, et al: Electrocardiographic changes in patients with rhabdomyomas, associated with tuberous sclerosis. Cardiol Young 2003;13:258-263.
33. Byard RW, Blumbergs PC, James RA: Mechanisms of unexpected death in tuberous sclerosis. J Forens Sci 2003;48: 172-176.
34. Rowley SA, O'Callaghan FJ, Osborne JP: Ophthalmic manifestations of tuberous sclerosis: A population based study. Br J Ophthalmol 2001;85:420-423.
35. Zimmer-Galler IE, Robertson DM: Long-term observation of retinal lesions in tuberous sclerosis. Am J Ophthalmol 1995; 119(3):318-324.
36. Beltramello A, Puppini G, Bricolo A, et al: Does the tuberous sclerosis complex include intracranial aneurysms? A case report with a review of the literature, review. Pediatr Radiol 1999; 29:206-211.
37. Jones BV, Tomsick TA, Franz DN: Guglielmi detachable coil embolization of a giant midbasilar aneurysm in a 19-month-old patient. AJNR Am J Neuroradiol 2002;23:1145-1148.
38. Dock M: Tuberous Sclerosis-Associated Enamel Pitting and Gingival Fibromas: Familial vs. Sporadic Disease; Genotype- Phenotype Correlations. Masters Thesis, Indiana University School of Dentistry, Indianapolis, IN, 2000.
39. Mlynarczyk G: Enamel pitting: A common symptom of tuberous sclerosis. Oral Surg Oral Med Oral Pathol 1991;71:63-67.